BFM
CLBT icon

Boothbay Fund Management’s Cellebrite CLBT Stock Holding History

Boothbay Fund Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,263
Closed -$431K – 2292
2026
Q1 		$431K Sell
31,263
-32,587
-51% -$491K 0.01% 1424
2025
Q4 		$1.15M Buy
63,850
+43,042
+207% +$773K 0.02% 750
2025
Q3 		$386K Buy
+20,808
New +$327K 0.01% 1313
2025
Q1 		– Sell
-50,978
Closed -$1.12M – 1447
2024
Q4 		$1.12M Sell
50,978
-32,424
-39% -$624K 0.03% 607
2024
Q3 		$1.4M Buy
83,402
+35,106
+73% +$521K 0.03% 642
2024
Q2 		$577K Buy
48,296
+35,048
+265% +$392K 0.01% 945
2024
Q1 		$147K Buy
+13,248
New +$135K ﹤0.01% 1376
2023
Q4 		– Sell
-56,623
Closed -$433K – 1687
2023
Q3 		$433K Buy
+56,623
New +$425K 0.01% 1094

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Boothbay Fund Management's CLBT Position: Q2 2026 in Review

Boothbay Fund Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 31,263 shares — an estimated $431K sold.

Boothbay Fund Management first reported a position in CLBT in Q3 2023 and held it in 8 quarters. The position peaked at $1.4M in Q3 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Boothbay Fund Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 31,263 Cellebrite shares in Q2 2026, an estimated $431K.
  • Boothbay Fund Management first reported a position in Cellebrite in Q3 2023 and held it in 8 quarters.
  • Boothbay Fund Management's Cellebrite position peaked at $1.4M in Q3 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.